๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

HLA and outcome in living donor liver transplantation in primary biliary cirrhosis: A new piece in the jigsaw?

โœ Scribed by Ye Htun Oo; James Neuberger

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
80 KB
Volume
13
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Outcome of living donor liver transplant
Outcome of living donor liver transplantation for post-Kasai biliary atresia in adults
โœ Yusuke Kyoden; Sumihito Tamura; Yasuhiko Sugawara; Noriyo Yamashiki; Yuichi Mats ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 123 KB ๐Ÿ‘ 1 views

Previous reports described the effectiveness of living donor liver transplantation (LDLT) for post-Kasai biliary atresia (BA) in the pediatric population. Information on the outcome of LDLT in patients that have reached adulthood after the Kasai procedure, however, is limited. A recent report postul

Effect of pretransplantation ursodeoxych
Effect of pretransplantation ursodeoxycholic acid therapy on the outcome of liver transplantation in patients with primary biliary cirrhosis
โœ Heathcote, E. Jenny ;Stone, Julie ;Cauch-Dudek, Karen ;Poupon, Raoul ;Chazouille ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› Wiley (John Wiley & Sons) ๐ŸŒ English โš– 42 KB

As ursodeoxycholic acid (UDCA) delays the need for transplantation, this could result in patients with more comorbid disease, therefore more likely to have a worse outcome posttransplantation. The aim of this study is to compare posttransplantation outcome in patients who received UDCA versus placeb

Living donor liver transplantation of th
Living donor liver transplantation of the right lobe for hepatocellular carcinoma in cirrhosis in a European center
โœ Sven Jonas; Jens Mittler; Andreas Pascher; Guido Schumacher; Tom Theruvath; Chri ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 220 KB ๐Ÿ‘ 1 views

Living donor liver transplantation of the right lobe might offer the possibility to extend the eligibility criteria of patients with hepatocellular carcinoma (HCC) in cirrhosis without penalizing patients who are waiting for a graft from a deceased donor. From 1988 to 2005, surgical treatment of HCC